FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Clears Game Ready Orthopedic Rehab Device

FDA clears a Game Ready 510(k) for its orthopedic rehabilitation device, the Med4 Elite.

Federal Register

Animal Drug User Fee Reauthorization Public Meeting

Federal Register notice: FDA announces a 11/2 public meeting entitled Animal Drug User Fee Act.

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 10/6/2017.

Federal Register

Regulatory Review Period Determined for Impella 2.5 System

Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Abiomed Europes Impella 2.5 System.

Federal Register

Regulatory Review Period Determined for Bayers Kovaltry

Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Bayers Kovaltry (antihemophilic factor (recombi...

Human Drugs

FDA Approves Flexion NDA for Knee Pain

FDA approves a Flexion Therapeutics NDA for Zilretta (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-arti...

Medical Devices

Sens. Warren, Grassley Call for Device Identifiers on Claims Forms

Senators Elizabeth Warren (D-MA) and Chuck Grassley (R-IA) call for medical device identifier information be added to Medicare claims in order to bett...

Human Drugs

FDA Approves Flexion NDA for Knee Pain

FDA approves a Flexion Therapeutics NDA for Zilretta (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-arti...

Human Drugs

Regulatory Review Period for Biogen Idecs Tecfidera

Federal Register notice: FDA has determined the regulatory review period for patent restoration purposes for Biogen Idecs Tecfidera (dimethyl fumarate...